These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24728517)

  • 21. The COP9 signalosome regulates Skp2 levels and proliferation of human cells.
    Denti S; Fernandez-Sanchez ME; Rogge L; Bianchi E
    J Biol Chem; 2006 Oct; 281(43):32188-96. PubMed ID: 16943200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study.
    Hompes D; D'Hoore A; Wolthuis A; Fieuws S; Mirck B; Bruin S; Verwaal V
    J Surg Oncol; 2014 May; 109(6):527-32. PubMed ID: 24375059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models.
    Lehmann K; Rickenbacher A; Jang JH; Oberkofler CE; Vonlanthen R; von Boehmer L; Humar B; Graf R; Gertsch P; Clavien PA
    Ann Surg; 2012 Nov; 256(5):730-7; discussion 737-8. PubMed ID: 23095616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of leukopenia and thrombocytopenia with cisplatin plus mitomycin-c versus melphalan in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Hakeam HA; Arab A; Azzam A; Alyahya Z; Eldali AM; Amin T
    Cancer Chemother Pharmacol; 2018 Apr; 81(4):697-704. PubMed ID: 29429054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C.
    Lange KN; McKay D; Gentry BG; Franko J
    Ann Surg Oncol; 2017 Dec; 24(13):3837-3841. PubMed ID: 29019106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morbidity associated with the use of oxaliplatin versus mitomycin C in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal or appendiceal origin: a multi-institutional comparative study.
    Benzaquen E; Wang Y; Wiseman S; Rosenfeld V; Sideris L; Dubé P; Pelletier JS; Vanounou T
    Can J Surg; 2021 Mar; 64(2):E111-E118. PubMed ID: 33651573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Arabidopsis COP9 signalosome is essential for G2 phase progression and genomic stability.
    Dohmann EM; Levesque MP; De Veylder L; Reichardt I; Jürgens G; Schmid M; Schwechheimer C
    Development; 2008 Jun; 135(11):2013-22. PubMed ID: 18434413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The COP9 signalosome inhibits p27(kip1) degradation and impedes G1-S phase progression via deneddylation of SCF Cul1.
    Yang X; Menon S; Lykke-Andersen K; Tsuge T; Di Xiao ; Wang X; Rodriguez-Suarez RJ; Zhang H; Wei N
    Curr Biol; 2002 Apr; 12(8):667-72. PubMed ID: 11967155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.
    Prada-Villaverde A; Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spiliotis J; Torres-Melero J; Turaga K; Trout R
    J Surg Oncol; 2014 Dec; 110(7):779-85. PubMed ID: 25088304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: a cDNA microarray analysis.
    Zhou QM; Chen QL; Du J; Wang XF; Lu YY; Zhang H; Su SB
    Int J Mol Sci; 2014 Sep; 15(9):16284-301. PubMed ID: 25226537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy.
    Pearce C; Hayden RE; Bunce CM; Khanim FL
    BMC Cell Biol; 2009 Apr; 10():31. PubMed ID: 19400951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulation of the COP9 signalosome-cullin-RING ubiquitin-ligase pathway: mechanisms and roles in urological cancers.
    Gummlich L; Rabien A; Jung K; Dubiel W
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1327-37. PubMed ID: 23583660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel anti-angiogenic compounds for application in tumor therapy - COP9 signalosome-associated kinases as possible targets.
    Braumann C; Tangermann J; Jacobi CA; Müller JM; Dubiel W
    Mini Rev Med Chem; 2008 May; 8(5):421-8. PubMed ID: 18473931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system.
    Bech-Otschir D; Kraft R; Huang X; Henklein P; Kapelari B; Pollmann C; Dubiel W
    EMBO J; 2001 Apr; 20(7):1630-9. PubMed ID: 11285227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stability.
    Korczeniewska J; Barnes BJ
    Mol Cell Biol; 2013 Mar; 33(6):1124-38. PubMed ID: 23275442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis.
    Leung V; Huo YR; Liauw W; Morris DL
    Eur J Surg Oncol; 2017 Jan; 43(1):144-149. PubMed ID: 27780675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The COP9 signalosome-mediated deneddylation is stimulated by caspases during apoptosis.
    Hetfeld BK; Peth A; Sun XM; Henklein P; Cohen GM; Dubiel W
    Apoptosis; 2008 Feb; 13(2):187-95. PubMed ID: 18060501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The COP9 signalosome negatively regulates proteasome proteolytic function and is essential to transcription.
    Su H; Huang W; Wang X
    Int J Biochem Cell Biol; 2009 Mar; 41(3):615-24. PubMed ID: 18706515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effects.
    Zhou QM; Wang XF; Liu XJ; Zhang H; Lu YY; Huang S; Su SB
    Eur J Cancer; 2011 Sep; 47(14):2240-7. PubMed ID: 21616659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis.
    Pelz JO; Doerfer J; Hohenberger W; Meyer T
    BMC Cancer; 2005 May; 5():56. PubMed ID: 15924622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.